James Klancke’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (2)


FIP/AAPS Guidelines to dissolution/in vitro release testing of novel/special dosage forms
  • Article
  • Full-text available

March 2003

·

924 Reads

·

326 Citations

AAPS PharmSciTech

Martin Siewert

·

Jennifer Dressman

·

·

[...]

·

Roger Williams
Download

Citations (2)


... Samples (5 ml) were removed at intervals (5, 10, 20, 30, 45, 60m), and volume was replaced with fresh dissolving media. Absorbance was noted at 234 nm after filtration and suitable dilution for the samples withdrawn (Shimadzu UV-1800, Japan) [13]. ...

Reference:

Solubility enhancement of etoricoxib using inclusion complexation with cyclodextrins: formulation of oro dispersible tablets by QbD approach
Dissolution Testing of Orally Disintegrating Tablets
  • Citing Article
  • January 2003

Dissolution Technologies

... Dissolution test is commonly used to ensure the quality and stability of both oral and non-oral dose forms. In another case, it can be utilized to forecast how specific products will behave in vivo [27] [28]. Additionally, dissolution testing is crucial in determining bioequivalence investigations regarding scale-up and post-approval modifications [29] [30]. ...

FIP/AAPS Guidelines to dissolution/in vitro release testing of novel/special dosage forms

AAPS PharmSciTech